Opioid Victims Have a Settlement. Will the Su...

Over the weekend, President Trump called off a trip to Pakistan by two of his negotiators for a potential additional round of talks with Tehran, leaving the fate of the cease-fire in limbo. Farnaz Fassihi, who covers Iran for The New York Times, looks at who is in charge of the c ...  Show more

With war, political wrangling and price hikes jockeying for headlines, it’s a rare thing to sit for an hour with a large group of strangers and focus on the small pleasures in life. But that’s what the show “Every Brilliant Thing” is all about. Since 2013, Duncan Macmillan’s audi ...  Show more

The Supreme Court recently blocked a bankruptcy deal that would have given full immunity to the members of the Sackler family who once controlled Purdue Pharma, the maker of OxyContin. Trevor Noah calls out the frustrating contradictions within the initial deal and shares his tho ...  Show more

The upcoming criminal trial of former Theranos CEO Elizabeth Holmes figures to center around one crucial question: Was the blood testing startup’s failure a case of misguided Silicon Valley over-ambition, or was it outright fraud? Law360’s Dorothy Atkins has been covering the The ...  Show more

The Biden administration on Tuesday shared the first ten prescription drugs that it has chosen for price negotiations through Medicare. The Biden administration will try to lower Medicare prices for the drugs by negotiating with their respective manufacturers to ease the burden o ...  Show more

Thanks to legal settlements with drug makers and distributors, states have plenty of money to boost prevention and treatment. Will it work? (Part two of a two-part series.)